Seroepidemiological study of human parvovirus B19 among human immunodeficiency virus-infected patients in a medium-sized city in Rio de Janeiro, Brazil

Memorias do Instituto Oswaldo Cruz

Volumn 104, Issue 6, 2009, Pages 901-904

  de Azevedo, Kátia Martins Lopes ^a   Setúbal, Sérgio ^a   Camacho, Luis Antônio Bastos ^b   Velarde, Luis Guillermo Coca ^a   de Oliveira, Solange Artimos ^a  

^a HOSPITAL UNIVERSITÁRIO ANTÔNIO PEDRO   (Brazil)

^b INSTITUTO OSWALDO CRUZ   (Brazil)

Author keywords

Anaemia; HIV infection; Human parvovirus B19; Seroprevalence

Indexed keywords

HUMAN IMMUNODEFICIENCY VIRUS; PARVOVIRUS;

EID: 70350268417     PISSN: 00740276     EISSN: 16788060     Source Type: Journal    
DOI: 10.1590/s0074-02762009000600014     Document Type: Article

References (16)

1. Abkowitz JL, Brown KE, Wood RW, Kovach NL, Green SW, Young NS 1997. Clinical relevance of parvovirus B19 as a cause of anemia in patients with human immunodeficiency virus infection. J Infect Dis 176: 296-273.
2. Aguiar FS, Lopes DP, Bazin AR, Setúbal S, Cohen BJ, Nascimento JP 2001. Human parvovirus B19 infection in HIV-positive patients. Rev Soc Bras Med Trop 34: 239-242.
3. Chernak E, Cubbin G, Henry D, Naides SJ, Hodinka RL, Macgregor RR, Friedman HM 1995. Infection due to parvovirus B19 in patients infected with human immunodeficiency virus. Clin Infect Dis 20: 170-173.
4. Frickhofen N, Abkowitz JL, Safford M, Berry M, Antunez-de-Mayolo J, Astrow A, Cohen R, Halperin I, King L, Mintzer D, Cohen B, Young NS 1990. Persistent B19 parvovirus infection in patients infected with human immunodeficiency virus type 1 (HIV-1): A treatable cause of anemia in AIDS. Ann Intern Med 113: 926-933.
5. Gyllensten K, Sönnerborg A, Jorup-Rönström C, Halvarsson M, Yun Z 1994. Parvovirus B19 infection in HIV-1 infected patients with anemia. Infection 22: 356-358.
6. Huatuco EM, Durignon EL, Lebrun FLAS, Passos SD, Gazeta RE, Azevedo Neto RS, Massad E 2008. Seroprevalence of human parvovirus B19 in a suburban population in São Paulo, Brazil. Rev Saude Publ 42: 443-449.
7. IBGE - Instituto Brasileiro de Geografia e Estatística 2008. Estimativas da população para 1o de julho de 2008. Available from: http:// www.ibge.gov.br. [accessed 9 december 2008].
8. Koduri PR 2000. Parvovirus B19-related anemia in HIV-infected patients. AIDS Patient Care STDS 14: 7-11.
9. Nascimento JP, Buckley MM, Brown KE, Cohen BJ 1990. The prevalence of antibody to human parvovirus B19 in Rio de Janeiro, Brazil. Rev Inst Med Trop Sao Paulo 32: 41-45.
10. Oliveira AS, Brandão AB, Fernandes DG, Bettini LR, Carvalho AB, Pereira ACM, Azevedo KML, Nascimento JP 1996. Human parvovirus B19 infection: Clinical and epidemiological study of 24 cases. Rev Inst Med Trop Sao Paulo 38: 323-327.
11. Raguin G, Leruez-Ville M, Gregoir V, Deplanche M, Leport C, Morinet F, Vilde JL 1997. Low prevalence of active parvovirus B19 infection in HIV-infected patients. Eur J Clin Microbiol Infect Dis 16: 760-762.
12. Silva ARA, Nogueira AS, Alzeguir JCL, Costa MCFL, Nascimento JP 2006. Prevalência de anticorpos IgG antiparvovirus B19 em gestantes durante o atendimento pré-natal e casos de hidropisia fetal não imune atribuídos ao parvovírus B19, na cidade do Rio de Janeiro. Rev Soc Bras Med Trop 39: 467-472.
13. Van Elsacker-Niele AMW, Kroon FP, Van der Wende ME, Salimans MMM, Spaan WJM, Kroes ACM 1996. Prevalence of parvovirus B19 infection in patients infected with human immunodeficiency virus. Clin Infect Dis 23: 1255-1260.
14. Vernazza PL, Pfister LA, Siegl G, Cassinotti P 1996. High seroprevalence of parvovirus B19 among patients infected with human immunodeficiency virus. Clin Infect Dis 22: 198-199.
15. Young NS, Brown KE 2004. Mechanisms of disease parvovirus B19. N Engl J Med 350: 586-597.
16. Zuckerman MA, Williams I, Bremner J, Cohen B, Miller RF 1994. Persistent anaemia in HIV-infected individuals due to parvovirus B19 infection. AIDS 8: 1191-1192.